SARS-CoV-2 Surrogate Virus Neutralization
Test Kit(E484K,K417T,N501Y) is a blocking ELISA detection tool, which mimics
the virus neutralization process. The kit contains two key components: the HRP labeled
recombinant human ACE2 and the SARS-CoV-2 RBD(E484K,K417T,N501Y)protein . The
protein-protein interaction between RBD(E484K,K417T,N501Y) and ACE2-HRP can be
blocked by neutralizing antibodies against SARS-CoV-2 RBD(E484K,K417T,N501Y).
SARS-CoV-2 Surrogate Virus Neutralization
Test Kit(E484K,K417T,N501Y) can detect circulating neutralizing antibodies
against SARS-CoV-2 that block the interaction between the receptor binding
domain of the viral spike glycoprotein RBD(E484K,K417T,N501Y) with the ACE2
cell surface receptor. The assay detects any antibodies in serum and plasma
that neutralize the RBD(E484K,K417T,N501Y)-ACE2 interaction. The test is both
species and isotype independent.
OTHER SUPPLIES REQUIRED
• Microplate reader capable of measuring absorbance at 450 nm, with the correction wavelength set at 540 nm or 570 nm.
• Pipettes and pipette tips.
• Deionized or distilled water.
• 500 mL graduated cylinder.
• Squirt bottle, manifold dispenser, or automated microplate washer.
• Test tubes for dilution of standards.
REAGENT PREPARATION
Bring all reagents to room temperature before use.
20-fold Wash Buffer Concentrate: if there is crystal precipitation in the Wash Buffer Concentrate, warm to room temperature and mix gently until the crystals have completely dissolved. Add 25 mL of Wash Buffer Concentrate to 475 mL of deionized or distilled water to prepare 500 mL of Wash Buffer.
Sample Preparation: Dilute test samples with Sample Dilution Buffer with a volume ratio of 1:9. For example, dilute 10 μL of sample with 90 μL of Sample Dilution Buffer
Positive Control: shake and mix before used. Centrifuge instantaneously with palm centrifuge to make the liquid at the bottom of the tube. Dilute the Positive Control 1:100 to the working concentration with Sample Dilution Buffer.
Negative Control: shake and mix before used. Centrifuge instantaneously with palm centrifuge to make the liquid at the bottom of the tube. Dilute the Negative Control 1:10 to the working concentration with Sample Dilution Buffer.
Detection A(HRP labeled): shake and mix before used. Centrifuge instantaneously with palm centrifuge to make the liquid at the bottom of the tube. Dilute the Detection A 1:2000 to the working concentration with Reagent Dilution Buffer.
Color Reagent TMB: Protect from light, Add 100μL of Color Reagent TMB to each well. Incubate for 8~10 minutes at room temperature.
Stop solution: 50μL/well after color development.
SAMPLE COLLECTION & STORAGE
The sample collection and storage conditions listed below are intended as general guidelines. Sample stability has not been evaluated.
Handle all blood and serum as if capable of transmitting infectious agents. The NCCLS provides recommendations for handling and storing serum and plasma specimens (Approved Standard-Procedures for the Handling and Processing of Blood Specimens, H18-A. 1990).
Serum - Use a serum separator tube (SST) and allow samples to clot for 30 minutes at room temperature before centrifugation for 15 minutes at 1000 x g. Remove serum and assay immediately or aliquot and store samples at ≤ -20℃. Avoid repeated freeze-thaw cycles.
Plasma - Collect plasma using EDTA, heparin, or citrate as an anticoagulant. Centrifuge for 15 minutes at 1000 x g within 30 minutes of collection. Assay immediately or aliquot and store samples at ≤ -20℃. Avoid repeated freeze-thaw cycles.
ASSAY PROCEDURE
Bring all reagents and samples to room temperature before use. It is recommended that all standards, controls, and samples be assayed in duplicate.
1. Prepare all reagents and working standards as directed in the previous sections.
2. Remove excess microplate strips from the plate frame, return them to the foil pouch containing the desiccant pack, and reseal.
3. In separate wells,add 50ul of diluted Positive Control, diluted Negative Control, or the diluted Samples.Cover the plate with Plate Sealer and incubate 30mins at 37℃.
4. Add 50 µL of diluted Detection A solution to each well.Set the plate on the microplate mixer with shaking 5mins.
5. Cover the plate with Plate Sealer and incubate 1 hour at 37℃.
6. Aspirate each well and wash, repeating the process three times. Wash by filling each well with Wash Buffer (300μL) using a squirt bottle, manifold dispenser, or autowasher. Complete removal of liquid at each step is essential to good performance. After the last wash, remove any remaining Wash Buffer by aspirating or decanting. Invert the plate and blot it against clean paper towels.
7. Add 100μL of Color Reagent TMB to each well. Incubate for 8~10 minutes at 37℃. Protect from light.
8. Add 50μL of Stop Solution to each well. The color in the wells should change from blue to yellow. If the color in the wells is green or the color change does not appear uniform, gently tap the plate to ensure thorough mixing.
9. Determine the optical density of each well within 10 minutes, using a microplate reader set to 450 nm. If wavelength correction is available, set to 540 nm or 570 nm. If wavelength correction is not available, subtract readings at 540 nm or 570 nm from the readings at 450 nm. This subtraction will correct for optical imperfections in the plate. Readings made directly at 450 nm without correction may be higher and less accurate.
INTERPRETATION OF RESULTS
To assure the validity of the results, each assay must include both Positive and Negative Controls. The net optical density (OD450) of each control must fall within the ranges listed in the following table. If OD450 values of controls do not meet the requirements in the following table, the test is invalid and must be repeated.
Items |
OD450 value |
Control Result for Valid Assay |
Positive Control |
< 0.3 |
Passed |
Negative Control |
> 0.9 |
Passed |
The positive cutoff and negative cutoff for SARS-CoV-2 neutralizing antibody detection can be used for interpretation of the inhibition rate. The operator can determine the result of the sample by comparing the inhibition rate to the following table.
Cutoff Interpretation
Items |
Cutoff |
Result |
Interpretation |
Neutralizing antibody test |
≥20% |
Positive |
Neutralizing antibody detected |
<20% |
Negative |
No detectable neutralizing antibody |
Precision
Intra-Assay Precision (Precision within an assay): <8%
Three samples of known concentration were tested twenty times on one plate to assess
intra-assay precision.
Inter-Assay Precision (Precision between assays): <10%
Three samples of known concentration were tested in twenty separate assays to assess
inter-assay precision.
Stability
When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 10%.
TROUBLESHOOTING GUIDE
Problem |
Probable Cause |
Solution |
Poor Precision |
Wells are not washed or aspirated properly |
Make sure the wash apparatus works properly and wells are dry after aspiration |
Bubbles in the wells |
Tap plate gently to disperse bubbles |
|
Wells are scratched with pipette tip or washing needles |
Dispense and aspirate solution into and out of wells with caution |
|
Particulates are found in the samples |
Remove any particulates by centrifugation prior to the assay |
|
High background |
Plate is not washed properly |
Make sure the wash apparatus works properly |
Incorrect incubation times and/or temperatures |
The OD value increased gradually along with the time.Reduce the color developing time properly |
|
Weak/No Signal |
Pipetting errors |
Make sure the pipette is calibrated |
The working solution not be prepared immediately before use |
The working solution should be prepared immediately before use and should not be stored |
|
Volumes errors |
Repeat assay with the required volumes in manual |
|
The plate is not incubated for proper time or temperature |
Follow the manual to repeat assay |
|
Detection A working solution is not completely mixed with the samples |
After adding the Detection A into the wells, make sure the detection A and the samples are mixed thoroughly |
MATERIALS PROVIDED & STORAGE CONDITIONS
PART |
Format |
Description |
STORAGE |
Capture Plate |
1 plate |
96 well polystyrene microplate (12 strips of 8 wells) coated with RBD(E484K,K417T,N501Y) protein. |
Store in sealed at - 20℃. |
Positive Control |
1 vial |
12μL/vial, 1mg/mL antibody specific for RBD protein with preservatives, 1:100 diluted by dilution buffer before used. Final concentration was 10μg /mL. |
Store at - 20℃. |
Negative Control |
1 vial |
60μL/vial, negative control with preservatives, 1:10 diluted by dilution buffer before used. |
Store at - 20℃. |
Detection A |
1 vial |
12μL/vial HRP labeled ACE2 protein (including preservative) , 1:2000 diluted by dilution buffer before used. |
Store at - 20℃. |
Sample Dilution Buffer |
1 bottle |
25 ml/bottle diluent (including preservative) was used to dilute the Positive Control ,Negative Control ,Serum and Plasma. |
Store at 4℃. |
Reagent Dilution Buffer |
1 bottle |
25 ml/bottle diluent (including preservative) was used to dilute the Detection A. |
Store at 4℃. |
Wash Buffer Concentrate |
1 bottle |
25 mL/bottle of a 20-fold concentrated solution of buffered surfactant with preservative. 1:20 diluted by deionized water before used. |
Store at 4℃. |
Color Reagent TMB |
1 bottle |
12 mL/ bottle of TMB(tetramethylbenzidine) . |
Store at 4℃. |
Stop Solution |
1 bottle |
6 mL/ bottle. |
Store at 4℃. |
Plate Sealer |
4 strips |
Adhesive strips. |
RT. |
* Provided this is within the expiration date of the kit.
Guarantee and Disclaimer:
After receiving the product, if finds that the product is mismatched, damaged or missing components, please keep the original package and submit the objection to the company by mail within seven working days. Failure to file an objection within the time limit is considered qualified.
When the buyer keeps the product, it should be kept in accordance with the storage conditions shown in the product label and the manual. If the product quality is caused by improper storage, it will not be guaranteed.
When the buyer tests the product, they should be submitted by the beginning of use when found the quality issue, rather than when the product was used or used up, in order to prepare our products for recycling and confirm the quality of the products. If it is the quality problem, our company is responsible for exchange or return. In the event of a claim, our company will compensate the discretion within the scope of the product price limit and will not accept any part of the value of the product itself. Since the date of receipt, the product has not been reflected for more than three months and should not be returned.
The products provided by our company are for research use only and should not be used for clinical diagnosis or treatment. If a unit or individual changes the use of our products without authorization, we will not bear any responsibility.